FDA Center for Biologics Evaluation & Research Issues Warning Letter to NexCell Scientific
September 23, 2026
September 23, 2026
WASHINGTON, Sept. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NexCell Scientific Inc. from its Center for Biologics Evaluation and Research:
* * *
Recipient: Edwin Pinos, President, NexCell Scientific Inc, 2 Hughes Ste 200, Irvine, CA 92618-2055, United States, ed@nexcellscientific.com
Issuing Office: Center for Biologics Evaluation and Research, United States
WARNI . . .
* * *
Recipient: Edwin Pinos, President, NexCell Scientific Inc, 2 Hughes Ste 200, Irvine, CA 92618-2055, United States, ed@nexcellscientific.com
Issuing Office: Center for Biologics Evaluation and Research, United States
WARNI . . .